Publication Complement Activation In Leprosy: A Retrospective Study Shows Elevated Circulating Terminal Complement Complex In Reactional Leprosy. Bahia El Idrissi N, Hakobyan S, Ramaglia V, et al. Clinical and experimental immunology. 2016; Download PDF
Publication Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients. Pinheiro R O, Oliveira E B, Dos Santos G, et al. Clinical and experimental immunology. 2013; 171 (2) : 210-9.
Publication The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. Souza Sales J, Lara F A, Amadeu T P, et al. Clinical and experimental immunology. 2011; 165 (2) : 251-63.
Publication Presence of intestinal helminths decreases T helper type 1 responses in tuberculoid leprosy patients and may increase the risk for multi-bacillary leprosy. Diniz L M, Magalhães E F L, Pereira F E L, et al. Clinical and experimental immunology. 2010; 161 (1) : 142-50. Download PDF
Publication Tryptophan aspartate-containing coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection. Tanigawa K, Suzuki K, Kimura H, et al. Clinical and experimental immunology. 2009; 156 (3) : 495-501. Download PDF
Publication Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions. Iyer A, Hatta M, Usman R, et al. Clinical and experimental immunology. 2007; 150 (2) : 210-6. Download PDF
Publication IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNgamma. Finiasz M R, Franco M C, De La Barrera S, et al. Clinical and experimental immunology. 2007; 147 (1) : 139-47. Download PDF
Publication The local immune response in ulcerative lesions of Buruli disease. Kiszewski A E, Becerril E, Aguilar L D, et al. Clinical and experimental immunology. 2006; 143 (3) : 445-51. Download PDF
Publication Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms. Dornelles L N, Pereira-Ferrari L, Messias-Reason LJT. Clinical and experimental immunology. 2006; 145 (3) : 463-8. Download PDF
Publication PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Ali S, Vollaard A M, Widjaja S, et al. Clinical and experimental immunology. 2006; 144 (3) : 425-31. Download PDF
Publication Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvement. Rojas-Espinosa O, Becerril-Villanueva E, Wek-Rodríguez K, et al. Clinical and experimental immunology. 2005; 140 (3) : 436-42. Download PDF
Publication NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13. De La Barrera S, Finiasz M, Fink S, et al. Clinical and experimental immunology. 2004; 135 (1) : 105-13. Download PDF
Publication Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Mahmoodi M, Khamesipour A, Dowlati Y, et al. Clinical and experimental immunology. 2003; 134 (2) : 303-8. Download PDF
Publication Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions. Kirkaldy A A, Musonda A C, Khanolkhar-Young S, et al. Clinical and experimental immunology. 2003; 134 (3) : 447-53. Download PDF
Publication Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen. Brahmbhatt S, Hussain R, Zafar S, et al. Clinical and experimental immunology. 2002; 128 (1) : 140-8. Download PDF
Publication High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy. Manandhar R, Shrestha N, Butlin C R, et al. Clinical and experimental immunology. 2002; 128 (2) : 333-8. Download PDF
Publication Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy. Goulart I M, Mineo J R, Foss N T. Clinical and experimental immunology. 2000; 122 (3) : 330-4. Download PDF
Publication Co-stimulatory signals increase the reactivity of gammadelta T cells towards mycobacterial antigens. González-Amaro R, Portales-Pérez D P, Baranda L, et al. Clinical and experimental immunology. 2000; 120 (3) : 468-75. Download PDF
Publication Onchocerciasis modulates the immune response to mycobacterial antigens. Stewart G R, Boussinesq M, Coulson T, et al. Clinical and experimental immunology. 1999; 117 (3) : 517-23. Download PDF
Publication Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Weir R E, Brennan P J, Butlin C R, et al. Clinical and experimental immunology. 1999; 116 (2) : 263-9. Download PDF